RENAL CARE GROUP, INC.
Table of Contents

 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549


FORM 8-K


CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): February 28, 2005

RENAL CARE GROUP, INC.


(Exact Name of Registrant as Specified in Charter)
         
Delaware   0-27640   62-1622383
         
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

2525 West End Avenue
Suite 600
Nashville, TN 37203

(Address of Principal Executive Offices, including Zip Code)

(615) 345-5500
(Registrant’s telephone number, including area code)

N/A


(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

 


TABLE OF CONTENTS

Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits
Item 2.02 Results of Operations and Financial Condition
SIGNATURE
INDEX TO EXHIBITS
EX-99.1 PRESS RELEASE


Table of Contents

Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits

     (c) Exhibits

Exhibit No.

     99.1 Press Release, dated February 28, 2005.

Item 2.02 Results of Operations and Financial Condition

     On February 28, 2005, Renal Care Group, Inc. issued a press release reporting on its financial results for the year ended December 31, 2004. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 


Table of Contents

SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
 


RENAL CARE GROUP, INC.
 
 
  By:   /s/ David M. Dill    
    David M. Dill   
    Executive Vice President and Chief
Financial Officer 
 
 

Dated: February 28, 2005

 


Table of Contents

INDEX TO EXHIBITS

     
EXHIBIT NO.   DESCRIPTION
99.1
  Press Release, dated February 28, 2005